Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXJY4E
|
||||
| Drug Name |
[3-(1H-Indol-3-yl)-propyl]-[2-(quinolin-8-yloxy)-ethyl]-amine
|
||||
| Synonyms |
CHEMBL340705
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C22H23N3O
|
||||
| Canonical SMILES |
C(CNCCOc1cccc2cccnc12)Cc3c[nH]c4ccccc34
|
||||
| InChI |
InChI=1S/C22H23N3O/c1-2-10-20-19(9-1)18(16-25-20)8-4-12-23-14-15-26-21-11-3-6-17-7-5-13-24-22(17)21/h1-3,5-7,9-11,13,16,23,25H,4,8,12,14-15H2
|
||||
| InChIKey |
IRZUEVZANGAMPR-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.